News
10% of sporadic colon tumors have mutations in the gene AMER1
Sanz-Pamplona R, Lopez-Doriga A, Paré-Brunet L, Lázaro K, Bellido F, Alonso MH, Aussó S, Guinó E, Beltrán S, Castro-Giner F, Gut M, Sanjuan X, Closa A, Cordero D, Morón-Duran FD, Soriano A, Salazar R, Valle L, Moreno V. Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer. Clinical Cancer Research 2015; 21(20):4709-18. doi: 10.1158/1078-0432.CCR-15-0159
IDIBELL is positioned in favor of Open Access policies
The Bellvitge Biomedical Research Institute (IDIBELL) has signed the statement of the League of European Research Universities (LERU) to promote Open Access policies in the dissemination of scientific results. According to the manifesto, European universities allocate a significant portion of their budgets to scientific journals publishers. Hundreds of millions of euro’s. Money which is not […]
IDIBELL participates in Giving Tuesday with the project ”Let research flies’
Funds will go to the IDIBELL Biomedical Research Grants Program aimed at young researchers About GivingTuesday
Carlos Fajardo, Helga Simon and Andrew Guinea, awarded in the first edition of PhDday
The symposium, organized by the PhD researchers on the campus, was a success
Montse Ballarín ”Innovation should be integrated in the culture of research institutions”
On November 24 the conference hall of the University Hospital of Bellvitge (HUB) hosted the presentation of the book ¿Innovas o trabajas? De la idea al paciente written by members of the IDIBELL Unity of Innovation Montse Ballarin, Jaime Ruiz, Eva Olivera and Jose Maria Sanchez, supported by ACC10. Those in charge of opening the […]
Evolution of severely immunosuppressed HIV patients depends on the immunologic and virologic response to treatment, regardless of the initial state
So far only it takes into account the baseline of the patients The study concludes that in spite that even in the worst scenario the patient may control the virus, treatment should begin from the time of diagnosis More than half of patients arrive late to treatment Article reference
UB, IDIBELL and the company FCTecnics collaborate on a project to develop a technology that allows advance the research of neurodegenerative d
The invention is an extensometer designed for researchers to conduct experiments of mechanical stress with large biological structures, such as nerves, tendons, muscles, in the search for neurodegenerative diseases such as Charcot-Marie -tooth. The project by the research group of Dr. Carlos Solsona, professor of the Department of Pathology and Experimental Therapeutics at the University […]